Form 4 for CNMD CONMED Corp
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-29 · accession 0001127602-25-016068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-30 | 2025-05-29 | CNMD | Farkas Charles | Dir | M - OptEx | $55.70 | +1,000 | 17.3K | +6% | +$55.7K |
| D | 2025-05-30 | 2025-05-29 | CNMD | Farkas Charles | Dir | F - Tax | $57.69 | -966 | 16.4K | -6% | -$55.7K |
| D | 2025-05-30 | 2025-05-29 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | -1,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-29 | M | A | 1,000 | $55.70 | 17,346 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-29 | F | D | 966 | $57.69 | 16,380 | D | — | — | |
| 3 | Derivative | SARs (Stock Appreciation Rights) | 2025-05-29 | M | D | 1,000 | $0.00 | 0 | D | $55.70 · 2016-06-01 to 2025-06-01 | 1,000 Common Stock | (F1) The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. |